Back to TYRA
TCG Crossover Management, LLC → TYRA
TCG Crossover Management, LLC TYRA Position History
Tyra Biosciences, Inc. • Healthcare
Quarters held
4
Latest value
$76M
Q3 2026
Peak value
$124.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $76.2M |
| Q1 2026 | $124.4M |
| Q2 2026 | $103.8M |
| Q3 2026 | $76M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $76M | 3.48M | — | — |
| Q2 2026 | $103.8M | 3.25M | — | — |
| Q1 2026 | $124.4M | 3.25M | — | — |
| Q4 2025 | $76.2M | 2.90M | — | — |
Other funds holding TYRA
$88.7B
$467.2M
$389.6M
$320.7M
$271M
$266.8M
$259.5M
$205.2M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC